Clinical Trial

Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors

Name: Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors — clinical trial record (NCT06820424)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, open-label, single-arm study to evaluate the safety and preliminary efficacy of anti-CDH17 CAR-T cells in patients with CDH17-positive advanced solid tumors.

Trial Details

NCT Number	NCT06820424
Lead Sponsor	920th Hospital of Joint Logistics Support Force of People's Liberation Army of China Collaborators: Guangzhou Bio-gene Technology Co., Ltd
Conditions	CDH17-positive Advanced Solid Tumors
Enrollment	30 participants
Start Date	2025-03
Primary Completion	2028-01 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2025-02-11